​

HealthEquity (HQY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HQY Stock Forecast

HealthEquity (HQY) stock forecast, based on 25 Wall Street analysts, predicts a 12-month average price target of $112.33, with a high of $115.00 and a low of $110.00. This represents a 36.17% increase from the last price of $82.49.

$65 $75 $85 $95 $105 $115 High: $115 Avg: $112.33 Low: $110 Last Closed Price: $82.49

HQY Stock Rating

HealthEquity stock's rating consensus is Buy, based on 25 Wall Street analysts. The breakdown includes 1 Strong Buy (4.00%), 22 Buy (88.00%), 2 Hold (8.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 25 2 22 1 Strong Sell Sell Hold Buy Strong Buy

HQY Price Target Upside V Benchmarks

TypeNameUpside
StockHealthEquity36.17%
SectorHealthcare Stocks 33.91%
IndustryHealthcare Information Services Stocks 34.92%

Price Target Trends

1M3M12M
# Anlaysts229
Avg Price Target$112.50$112.50$106.56
Last Closing Price$82.49$82.49$82.49
Upside/Downside36.38%36.38%29.18%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25491--14
Mar, 25581--14
Feb, 25581--14
Jan, 25581--14
Dec, 24681--15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 25, 2025Strong BuyRaymond James$115.00$90.1927.51%39.41%
Dec 10, 2024Alexander ParisBarrington$112.00$95.3917.41%35.77%
Sep 04, 2024George HillDeutsche Bank$103.00$82.6624.61%24.86%
Jun 20, 2024Stan BerenshteynWells Fargo$110.00$84.7429.81%33.35%
Jun 04, 2024Scott SchoenhausKeyBanc$100.00$83.4019.90%21.23%
Jun 04, 2024Mark MarconRobert W. Baird$104.00$81.2228.05%26.08%
Jun 03, 2024Alexander ParisBarrington$100.00$81.0323.41%21.23%
May 07, 2024Stan BerenshteynWells Fargo$105.00$79.2732.46%27.29%
Apr 04, 2024Constantine DavidesJMP Securities$101.00$79.9026.41%22.44%
Mar 28, 2024Glen SantangeloJefferies$95.00$79.7219.17%15.17%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 25, 2025Raymond JamesOutperformStrong Buyupgrade
Dec 10, 2024JMP SecuritiesOutperformOutperformhold
Sep 20, 2024RBC CapitalBuyBuyhold
Sep 19, 2024RBC CapitalOutperformOutperformhold
Sep 04, 2024KeyBancOverweightOverweighthold
Sep 04, 2024Deutsche BankBuyBuyhold
Jun 04, 2024Wells FargoBuyBuyhold
Jun 04, 2024KeyBancOverweightOverweighthold
Jun 04, 2024Bank of America SecuritiesBuyBuyhold
Jun 04, 2024JMP SecuritiesOutperformOutperformhold

Financial Forecast

EPS Forecast

$-1 $0 $1 $2 $3 $4 $5 $6 Jan 21 Jan 22 Jan 23 Jan 24 Jan 25 Jan 26 Jan 27 Jan 28
Jan 21Jan 22Jan 23Jan 24Jan 25Jan 26Jan 27Jan 28
Reported$0.12$-0.53$-0.31$0.65$1.11---
Avg Forecast$1.67$1.33$1.33$2.20$3.15$3.71$4.52$5.45
High Forecast$1.69$1.35$1.41$2.25$3.16$3.97$5.69$5.76
Low Forecast$1.63$1.31$1.31$2.13$3.12$3.63$3.45$5.35
Surprise %-92.81%-139.85%-123.31%-70.45%-64.76%---

Revenue Forecast

$500M $800M $1B $1B $2B $2B Jan 21 Jan 22 Jan 23 Jan 24 Jan 25 Jan 26 Jan 27 Jan 28
Jan 21Jan 22Jan 23Jan 24Jan 25Jan 26Jan 27Jan 28
Reported$733.57M$756.56M$861.75M$999.59M$1.20B---
Avg Forecast$731.18M$753.12M$858.80M$995.66M$1.19B$1.30B$1.44B$1.73B
High Forecast$740.03M$762.24M$896.39M$999.18M$1.20B$1.38B$1.45B$1.80B
Low Forecast$720.41M$742.03M$847.24M$992.71M$1.18B$1.28B$1.44B$1.70B
Surprise %0.33%0.46%0.34%0.39%0.51%---

Net Income Forecast

$-50M $70M $190M $310M $430M $550M Jan 21 Jan 22 Jan 23 Jan 24 Jan 25 Jan 26 Jan 27 Jan 28
Jan 21Jan 22Jan 23Jan 24Jan 25Jan 26Jan 27Jan 28
Reported$8.83M$-44.29M$-26.14M$55.71M$96.70M---
Avg Forecast$144.80M$-6.21M$115.98M$29.14M$94.29M$330.09M$397.45M$473.92M
High Forecast$147.08M$-2.93M$122.58M$34.97M$95.50M$344.82M$494.96M$500.88M
Low Forecast$142.03M$-9.50M$113.95M$23.31M$93.09M$315.36M$299.95M$465.62M
Surprise %-93.90%612.72%-122.54%91.19%2.56%---

HQY Forecast FAQ

Is HealthEquity stock a buy?

HealthEquity stock has a consensus rating of Buy, based on 25 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 22 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that HealthEquity is a favorable investment for most analysts.

What is HealthEquity's price target?

HealthEquity's price target, set by 25 Wall Street analysts, averages $112.33 over the next 12 months. The price target range spans from $110 at the low end to $115 at the high end, suggesting a potential 36.17% change from the previous closing price of $82.49.

How does HealthEquity stock forecast compare to its benchmarks?

HealthEquity's stock forecast shows a 36.17% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the healthcare information services stocks industry (34.92%).

What is the breakdown of analyst ratings for HealthEquity over the past three months?

  • April 2025: 28.57% Strong Buy, 64.29% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 35.71% Strong Buy, 57.14% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 35.71% Strong Buy, 57.14% Buy, 7.14% Hold, 0% Sell, 0% Strong Sell.

What is HealthEquity’s EPS forecast?

HealthEquity's average annual EPS forecast for its fiscal year ending in January 2026 is $3.71, marking a 234.23% increase from the reported $1.11 in 2025. Estimates for the following years are $4.52 in 2027, and $5.45 in 2028.

What is HealthEquity’s revenue forecast?

HealthEquity's average annual revenue forecast for its fiscal year ending in January 2026 is $1.3B, reflecting a 8.31% increase from the reported $1.2B in 2025. The forecast for 2027 is $1.44B, and $1.73B for 2028.

What is HealthEquity’s net income forecast?

HealthEquity's net income forecast for the fiscal year ending in January 2026 stands at $330.09M, representing an 241.35% increase from the reported $96.7M in 2025. Projections indicate $397.45M in 2027, and $473.92M in 2028.